表紙
市場調査レポート

日本の病院の微生物検査市場

Japan Hospital Infectious Disease Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

発行 Venture Planning Group 商品コード 259616
出版日 ページ情報 英文 891 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.75円で換算しております。

Local License: 同一事業所内

Back to Top
日本の病院の微生物検査市場 Japan Hospital Infectious Disease Testing Market: Emerging Opportunities and Growth Strategies for Suppliers
出版日: ページ情報: 英文 891 Pages
担当者のコメント
このシリーズは、他にも調査対象国がございます。詳細はお問合せください。
概要

当レポートでは、日本の病院の微生物検査市場について調査分析し、世界市場と技術の概要、日本市場の現状と将来予測を提供するほか、主な製品開発機会、市場参入戦略などを検証し、主要企業プロファイルも含め、概略以下の構成でお届けいたします。

イントロダクション

世界市場と技術の概要

  • 主な感染症の検査(全68種)
    • エイズ(AIDS)
    • アデノウイルス
    • エロモナス
    • 炭疽病/炭疽菌
    • アルボウイルス
    • バベシア症
    • 細菌性血管腫症(BEA)
    • ブルセラ菌
    • カンピロバクター
    • カンジダ
    • シャーガス病
    • 軟性下疳
    • クラミジア
    • クロストリジウム・ディフィシレ
    • コロナウイルス
    • コクサッキーウイルス
    • クロイツフェルト・ヤコブ病
    • クリプトスポリジウム
    • シクロスポラ
    • サイトメガロウイルス
    • エボラウイルス
    • 大腸菌
    • エコーウイルス
    • 脳炎
    • エンテロウイルス
    • エプスタイン・バーウイルス
    • ランブル鞭毛虫
    • 淋病
    • 鼠径部肉芽腫
    • ハンタウイルス
    • ピロリ菌
    • 肝炎
    • 単純ヘルペスウイルス
    • ヒトヘルペスウイルス6型
    • インフルエンザウイルス
    • レジオネラ
    • ライム病
    • 鼠径リンパ肉芽腫
    • マラリア
    • はしか
    • 髄膜炎
    • 微胞子虫目
    • 単核症
    • おたふく風邪
    • マイコプラズマ
    • パピロマウイルス
    • パルボウイルス B19
    • 肺炎
    • ポリオーマウイルス
    • 緑膿菌
    • 狂犬病
    • 呼吸器合胞体ウイルス
    • ライノウイルス
    • ロタウイルス
    • 風疹
    • サルモネラ菌
    • 敗血症
    • 細菌性赤痢
    • 黄色ブドウ球菌
    • 連鎖球菌
    • 梅毒
    • トキソプラズマ症
    • 膣トリコモナス
    • 結核
    • ビブリオ
    • 西ナイルウイルス
    • エルシニア
  • 主要分析器の装置レビュー
  • 新興の診断技術
    • 分子診断
    • モノクローナル抗体
    • イムノアッセイ
    • 差分光散乱
    • IT
    • 人工知能
    • リポソーム
    • フローサイトメトリー
    • クロマトグラフィ
    • 画像診断
    • ゲル微液滴
    • その他

日本市場

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場規模、成長率、主要サプライヤー

主な製品開発機会

  • 装置
  • 試薬キットと検査システム/パネル
  • コンピューター、ソフトウェア、オートメーション
  • 付属品

分散型検査製品の設計基準

代替的な市場普及戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 分散型検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新興のサプライヤー
    • 主な流通業者のタイプ
    • 市場セグメント

潜在的な市場参入障壁とリスク

  • 市場の成熟
  • 費用抑制
  • 競合
  • 技術面での優位性と限界
  • 特許権保護
  • 規制上の制約
  • 分散型検査市場の課題

競合企業プロファイル

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • 栄研化学
  • Enzo Biochem
  • 富士レビオ
  • Gen-Probe
  • Hologic
  • ID Biomedical
  • Innogenetics/Solvay
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • タカラバイオ
  • Thermo Fisher
  • Wallac
  • 和光純薬工業

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPID19605

This new report from VPGMarketResearch.com contains 891 pages, 75 tables, and presents a comprehensive analysis of the Japanese hospital infectious disease testing market, including: 

  • Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. 
  • Current scientific views on definition, epidemiology, and etiology of major infectious diseases and microorganisms. 
  • Volume and sales forecasts for 80 infectious disease tests performed in Japanese hospital laboratories. 
  • Instrumentation technologies and feature comparison of leading analyzers. 
  • Sales and market shares of leading suppliers. 
  • Emerging diagnostic technologies and their potential market applications. 
  • Product development opportunities. 
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. 
  • Business opportunities and strategic recommendations for suppliers. 

        Contains 891 pages and 75 tables
   

Table of Contents

Introduction

Worldwide Market and Technology Overview

A. Major Infectious Disease Tests

  • 1. AIDS
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 2. Adenovirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
    • d. Adeno-Associated Viruses(AAV)
  • 3. Aeromonas
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 4. Anthrax/Bacillus Anthracis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 5. Arboviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 6. Babesiosis
    • a. Background
  • 7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 8. Blastocystis Hominis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 9. Brucella
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 10. Campylobacter
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 11. Candida
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 12. Chagas Disease
    • a. Background
  • 13. Chancroid
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 14. Chlamydia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 15. Clostridium Difficile
    • a. Background
    • b. Diagnostic Tests
    • c. Drugs and Vaccines
  • 16. Coronaviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 17. Coxsackieviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 18. Creutzfeldt-Jakob's Disease
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines
  • 19. Cryptosporidium Parvum
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 20. Cyclospora Cayetanensis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 21. Cytomegalovirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 22. Ebola Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 23. E. Coli
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 24. EchoVirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 25. Encephalitis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 26. Enteroviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 27. Epstein-Barr Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 28. Giardia Lamblia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 29. Gonorrhea
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 30. Granuloma Inguinale
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 31. Hantavirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 32. Helicobacter Pylori
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 33. Hepatitis
    • a. Background
    • b. Hepatitis A
    • c. Hepatitis B
    • d. Hepatitis C
    • e. Vaccines and Drugs
  • 34. Herpes Simplex Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 35. Human Herpes Virus-6 (HHV-6)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 36. Influenza Viruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 37. Legionella
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
    • 38. Lyme Disease
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 39. Lymphogranuloma Venereum (LGV)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 40. Malaria
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 41. Measles (Rubeola)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 42. Meningitis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 43. Microsporidium
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 44. Mononucleosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 45. Mumps
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 46. Mycoplasma
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 47. Papillomaviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 48. Parvovirus B19
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 49. Pneumonia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 50. Polyomaviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 51. Pseudomonas Aeruginosa
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 52. Rabies
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 53. Respiratory Syncytial Virus (RSV)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 54. RhinoViruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 55. RotaVirus (REOVIRUS)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 56. Rubella(MEASLES)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 57. Salmonellosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 58. Septicemia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 59. Shigellosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 60. Staphylococcus Aureus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 61. Streptococci
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 62. Syphilis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 63. Toxoplasmosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 64. Trichomonas Vaginalis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 65. Tuberculosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 66. Vibrio
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 67. West Nile Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 68. Yersina
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs

B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers

C. Emerging Diagnostic Technologies

  • 1. Molecular Diagnostics
  • 2. Monoclonal Antibodies
  • 3. Immunoassays
  • 4. Differential Light Scattering
  • 5. Information Technology
  • 6. Artificial Intelligence
  • 7. Liposomes
  • 8. Flow Cytometry
  • 9. Chromatography
  • 10. Diagnostic Imaging
  • 11. Gel Microdroplets
  • 12. Other

Japan

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers

Major Product Development Opportunities

  • A. Instrumentation
  • B. Reagent Kits and Test Systems/Panels
  • C. Computers, Software and Automation
  • D. Auxiliary Products

Design Criteria for Decentralized Testing Products

  • Alternative Market Penetration Strategies
  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Competitive Assessments

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Enzo Biochem
  • Fujirebio
  • Gen-Probe
  • Hologic
  • ID Biomedical
  • Innogenetics/Solvay
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher
  • Wallac
  • Wako

List of Tables

  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Adenovirus Tests
  • Major Companies Developing or Marketing Bartonella Tests
  • Major Companies Developing or Marketing Campylobacter Tests
  • Major Companies Developing or Marketing Candida Tests
  • Major Companies Developing or Marketing Chlamydia Tests
  • Major Companies Developing or Marketing Clostridium Tests
  • Major Companies Developing or Marketing Coronavirus Tests
  • Major Companies Developing or Marketing Cryptosporidium Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing Echovirus Tests
  • Major Companies Developing or Marketing Enterovirus Tests
  • Major Companies Developing or Marketing EBV Tests
  • Major Companies Developing or Marketing Giardia Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Hantavirus Tests
  • Major Companies Developing or Marketing Helicobacter Pylori Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Influenza Tests
  • Major Companies Developing or Marketing Legionella Tests
  • Major Companies Developing or Marketing Lyme Disease Tests
  • Major Companies Developing or Marketing Lymphogranuloma Tests
  • Major Companies Developing or Marketing Malaria Tests
  • Major Companies Developing or Marketing Measles Tests
  • Major Companies Developing or Marketing Meningitis Tests
  • Major Companies Developing or Marketing Microsporidium Tests
  • Major Companies Developing or Marketing Mononucleosis Tests
  • Major Companies Developing or Marketing Mumps Tests
  • Major Companies Developing or Marketing Mycoplasma Tests
  • Major Companies Developing or Marketing Papilloma Virus Tests
  • Major Companies Developing or Marketing Parvovirus Tests
  • Major Companies Developing or Marketing Pneumonia Tests
  • Major Companies Developing or Marketing RSV Tests
  • Major Companies Developing or Marketing Rotavirus Tests
  • Major Companies Developing or Marketing Rubella Tests
  • Major Companies Developing or Marketing Salmonella Tests
  • Major Companies Developing or Marketing Septicemia Tests
  • Major Companies Developing or Marketing Shigella Tests
  • Major Companies Developing or Marketing Staphylococci Tests
  • Major Companies Developing or Marketing Streptococci Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • Major Companies Developing or Marketing Toxoplasmosis Tests
  • Major Companies Developing or Marketing Trichomonas Tests
  • Major Companies Developing or Marketing Tuberculosis Tests
  • Major Companies Developing or Marketing West Nile Tests
  • Major Companies Developing or Marketing Yersinia Tests
  • Japan Summary Table All Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan Hospital Laboratories Performing Infectious Disease Tests by Bed Size
  • Japan Hospital Laboratories Infectious Disease Test Volume Forecast
  • Japan Hospital Laboratories Infectious Disease Diagnostics Market Forecast
  • Japan AIDS Testing Market Diagnostics Sales by Major Supplier
  • Japan Campylobacter Testing Market Diagnostics Sales by Major Supplier
  • Japan Candida Testing Market Diagnostics Sales by Major Supplier
  • Japan Chlamydia Testing Market Diagnostics Salesby Major Supplier
  • Japan CMV Testing Market Diagnostics Sales by Major Supplier
  • Japan Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • Japan Hepatitis Testing Market Diagnostics Sales by Major Supplier
  • Japan Hepatitis C Testing Market Diagnostics Sales by Major Supplier
  • Japan Herpes Testing Market Diagnostics Sales by Major Supplier
  • Japan Legionella Testing Market Diagnostics Sales Forecast by Major Supplier
  • Japan Meningitis Testing Market Diagnostics Sales by Major Supplier
  • Japan Mononucleosis Testing Market Diagnostics Sales by Major Supplier
  • Japan Mycoplasma Testing Market Diagnostics Sales by Major Supplier
  • Japan Pneumonia Testing Market Diagnostics Sales by Major Supplier
  • Japan RSV Testing Market Diagnostics Sales by Major Supplier
  • Japan Rotavirus Testing Market Diagnostics Sales by Major Supplier
  • Japan Rubella Testing Market Diagnostics Sales by Major Supplier
  • Japan Septicemia Testing Market Diagnostics Sales by Major Supplier
  • Japan Shigella Testing Market Diagnostics Sales by Major Supplier
  • Japan Streptococci Testing Market Diagnostics Sales by Major Supplier
  • Japan Syphilis Testing Market Diagnostics Sales by Major Supplier
  • Japan Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
  • Japan Trichomonas Testing Market Diagnostics Sales by Major Supplier
  • Japan Tuberculosis Testing Market Diagnostics Sales by Major Supplier
Back to Top